Predictors of Interest in an Alcohol Reduction Clinical Trial of Naltrexone among UndergraduatesRobert F Leeman1*, William R Corbin2, Lisa M Fucito1, John W Urwin1 and Stephanie S O’Malley1
- *Corresponding Author:
Robert F Leeman
School of Medicine, Yale University , USA
E-mail: [email protected]
Received date: April 12, 2013; Accepted date: May 10, 2013; Published date: May 24, 2013
Citation: Leeman RF, Corbin WR, Fucito LM, Urwin JW, O’Malley SS (2013) Predictors of Interest in an Alcohol Reduction Clinical Trial of Naltrexone among Undergraduates. J Addict Res Ther 4:151. doi:10.4172/2155-6105.1000151
Copyright: © 2013 Leeman RF, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Background: We tested predictors of interest in a clinical trial of naltrexone plus counseling for heavy drinking reduction in young adults using a web survey. Respondents could indicate interest in the clinical trial at the conclusion of the survey.
Methods: A random sample of university students completed the survey (N = 584, 60% female). Data were collected in October-November 2010.
Results: Among past-year drinkers (n = 411), 22.6% (n = 93) indicated interest. Equivalent levels of interest were found among past-year heavy drinkers. Non-white race and current cigarette smoking predicted interest. Alcoholrelated negative consequences score was a trend-level predictor in the full regression model, but a significant predictor in a reduced model.
Conclusions: Non-white students, smokers and those with a high number of negative consequences may be more amenable to drinking reduction via medication and counseling. These findings could facilitate efforts of researchers, administrators, counselors and other professionals to tailor drinking reduction messages and facilitate treatment engagement by undergraduates.